case_images: PMC10868628_01
case_images: 68Ga - DOTANOC PET/CT images of the patient . (A) MIP; (B, D, & F) axial view of CT; (C, E, & G) axial view of 68Ga - DOTANOC PET/CT fusion. Image A shows DOTANOC uptake in the region of the prostate (black arrow), pelvic lymph nodes (red arrow), and skeletal metastatic sites in the region of the left humerus and right femur (blue arrows). Images B & C reveal prostate mass with DOTANOC uptake suggesting somatostatin receptor-expressing neoplastic disease (white arrows). Images D & E show bilateral iliac lymph nodes with DOTANOC uptake (white arrows). Images F & G show a sclerotic lesion involving the sacrum with DOTANOC uptake (white arrows).. MIP: Maximal intensity projection; 68Ga-DOTANOC PET/CT: 68Gallium-labeled DOTANOC positron emission tomography/computed tomography.
case_images: cureus-0016-00000052375-i01.jpg
case_images: PMC10868628_01_cureus-0016-00000052375-i01.jpg
case_images: FIG1
case_images: Findings (Figures 1A-1G) revealed DOTANOC avid soft tissue lesions involving the entire prostate gland (SUVmax 67.4).